SlideShare a Scribd company logo
Custom-made medical devices
Information for the dental industry
Valerie Mercer
Director Medical Devices Information and Education
Medical Devices Branch
Therapeutic Goods Administration
ADIA industry briefing 12-13 July 2016
Discussion topics
• Legislative framework
• What is custom-made?
• Notifying TGA
• Regulatory obligations
- pre-market
- post-market
ADIA industry briefing 12-13 July 2016 1
Regulatory framework
Commonwealth legislation
• Therapeutic Goods Act 1989
especially Chapter 4 Medical Devices
• Therapeutic Goods (Medical Devices)
Regulations 2002
• https://www.tga.gov.au/legislation-legislative-instruments
ADIA industry briefing 12-13 July 2016 2
https://www.legislation.gov.au/Series/C2004A03952
3
https://www.legislation.gov.au/Series/F2002B00237 4
Definitions
Medical device
• s41BD of the Act defines
a medical device as …
ADIA industry briefing 12-13 July 2016 5
Definitions
Custom-made medical device
• the Regulations define
a custom-made medical
device as ….
• examples relevant to the
dental industry may include:
- crowns
- bridges
- dentures
- specialised instruments
ADIA industry briefing 12-13 July 2016 6
‘Customised’ does not equal a custom-made
medical device
• an existing medical device that is adapted, altered, fashioned, modified or ‘customised’ to fit a patient is
NOT a custom-made medical device
• for example, a preformed permanent dental crown
that may require minimal fashioning in situ during
restorative work is not a custom-made medical device
• devices already included on the ARTG that are combined
and adapted for an individual (provided the devices are
used as intended by the manufacturer/IFUs) are not
custom-made medical devices (orthodontic braces)
ADIA industry briefing 12-13 July 2016 7
Definitions
Manufacturer
• s41BG of the Act defines
a manufacturer as …
ADIA industry briefing 12-13 July 2016 8
Definitions
Sponsor
• s3 of the Act defines
a sponsor as …
• sometimes the sponsor and the
manufacturer are the same entity
e.g. a dental laboratory that
supplies their products directly
to dental professionals
• dentists and allied oral healthcare
providers can import custom-made
devices from overseas, but in doing
so they become the sponsor and
acquire obligations
9
Definitions
Kinds of devices
• s41BE of the Act defines
kinds of medical devices as …
• TGA needs to be notified of each
kind of device
• TGA does not need to be notified
about each individual device being
made for individual patients
ADIA industry briefing 12-13 July 2016 10
Kinds of medical devices - examples
Example 1
Dentist (sponsor) imports polymer dental bridges
manufactured by Manufacturer A in China:
- same sponsor
- same manufacturer
- same GMDN code
- same classification
Therefore same kind of medical device and only
one notification to TGA required.
Do not need to notify TGA for each patient
receiving a custom-made medical device of this
kind.
Example 2
Dentist (sponsor) imports polymer dental bridges
manufactured by Manufacturer A in China and
Manufacturer B in Germany:
- same sponsor
- different manufacturers
- same GMDN code
- same classification
Therefore not the same kind of medical device and
separate notifications required for each kind.
Again, do not need to notify TGA for each patient, only
the kind of device.
ADIA industry briefing 12-13 July 2016
11
Regulatory obligations
Who has obligations?
• both the manufacturer and the sponsor have obligations
• requirements to:
- meet the essential principles (EPs) - this demonstrates the quality, safety and performance of the device
- apply a conformity assessment procedure - this generates evidence that the device complies with the EPs
- notify the TGA
- comply with advertising requirements
- report adverse events
But aren’t custom-made devices ‘exempt’?
• exempt from ARTG inclusion only
• all other obligations still apply
ADIA industry briefing 12-13 July 2016 12
Requirement to notify TGA
• since 2002, Australian manufacturers
and sponsors importing custom-made
medical devices into Australia have
been required to notify TGA about
certain details, e.g. name and
business address, description of the
‘kind of device’
• in February 2016 the regulations were
amended to introduce a two month
timeframe for notification to the TGA
• details in Regulation 10.3
ADIA industry briefing 12-13 July 2016 13
How to notify …
• simple web-based notification form
• quick and easy to complete and submit
• some fields mandatory
• within 2 months of the device being
manufactured in Australia or
first imported into Australia
www.tga.gov.au/custom-made-medical-devices
ADIA industry briefing 12-13 July 2016 14
15
16
17
19
20
Other regulatory obligations
Essential Principles
• Regulations Schedule 1, Part 1 (general principles) and Part 2 (principles about design and construction)
• manufacturer must meet the applicable essential principles
• sponsor must ensure device meets applicable essential principles
• some EPs may not apply to the device (e.g. if the custom-made medical device is not supplied in a sterile
state, the essential principles regarding sterility are not relevant and will not need to be met)
• some essential principles apply only to custom-made medical devices:
- information that must be provided with a medical device - an indication that the device has been custom-
made for a particular individual or health professional and is intended for use only by that individual or health
professional must be provided with a custom-made medical device
- instructions for use (if required) must include an indication that the device has been custom-made for a
particular individual or health professional and is intended for use only by that individual or health
professional
• there is an ‘essential principles checklist’ on TGA’s website which may be helpful (not mandatory)
ADIA industry briefing 12-13 July 2016 21
Other regulatory obligations
Conformity assessment procedures
The manufacturer is required to:
• prepare and sign a written statement containing specific information (detailed in the Regs sched 3 item 7.2)
• prepare documentation relating to the design, production and intended performance of the device
(and keep the documentation up-to-date)
• take all measures necessary to ensure that the manufacturing process results in the device complying
with the documentation mentioned above
• notify the TGA as soon as practicable of certain events that might lead (or might have led) to the death or
serious deterioration of the state of health of the patient or user, or caused the manufacturer to recover a
device that has been distributed. Examples of these events include malfunction, deterioration and inadequacy
in the design, production, labelling or instructions for use.
The sponsor is required to ensure that the manufacturer has applied the conformity assessment procedures.
ADIA industry briefing 12-13 July 2016 22
About the ‘statement’
Details to be included:
• name and business address of manufacturer
• information to identify the device
• statement that manufacturer intends device to be used only for a particular individual or health professional
• name of the individual or health professional
• name and business address of health professional that provided device specifications
• particular design characteristics or construction provided by health professional
• a statement that the device complies with the applicable essential principles, or a statement explaining which
essential principles it does not comply with and reasons for the non-compliance
Statement to be signed and dated by an authorised person (from the manufacturer) and kept up-to-date
ADIA industry briefing 12-13 July 2016 23
Therapeutic Goods Advertising Code 2015
General Principles
Section 4 sets out the key requirements including that therapeutic good advertisements “must not”:
• Mislead or be likely to mislead
• Arouse unrealistic expectations of product effectiveness
• Lead consumers to self-diagnosing, inappropriately treating or believing they have a serious disease
• Abuse consumers’ trust or exploit their lack of knowledge
• Encourage inappropriate or excessive use
• Claim that a good is guaranteed, certain, sure cure or that the goods are completely safe or harmless
• Be directed to minors (subject to exceptions)
https://www.legislation.gov.au/Details/F2015L01787
ADIA industry briefing 12-13 July 2016 24
Adverse events
What to report
25ADIA industry briefing 12-13 July 2016
Summary
• Both manufacturers and sponsors/suppliers of custom-made medical devices have obligations
• ‘Custom-made’ has a specific meaning and is defined in the regulatory framework (not customised/adapted)
• Custom-made devices have specific requirements for information to be supplied with the device
• Custom-made devices are exempt from ARTG inclusion, but other obligations still apply
• Timeframe for notifying TGA of custom-made devices is 2 months
- from initial manufacture (if manufactured in Australia)
- from initial importation/supply in Australia (if manufactured overseas)
• Notifying TGA is only one obligation – others include:
- device must meet essential principles
- device must have had conformity assessment procedure applied
- adverse events must be reported to TGA
ADIA industry briefing 12-13 July 2016 26
Presentation: Custom-made medical devices: Information for the dental industry

More Related Content

What's hot

MHRA - 18th March 2014
MHRA - 18th March 2014MHRA - 18th March 2014
MHRA - 18th March 2014
Anthony A Hill
 
The regulation of IVD medical devices
The regulation of IVD medical devicesThe regulation of IVD medical devices
The regulation of IVD medical devices
TGA Australia
 
New EU Legislation on Medical Devices By G. Bos - BSI (Qserve Conference 2013)
New EU Legislation on Medical Devices By G. Bos - BSI (Qserve Conference 2013)New EU Legislation on Medical Devices By G. Bos - BSI (Qserve Conference 2013)
New EU Legislation on Medical Devices By G. Bos - BSI (Qserve Conference 2013)
qserveconference2013
 
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
Medical Devices Regulation (MDR)  2017/745 - Clinical investigationsMedical Devices Regulation (MDR)  2017/745 - Clinical investigations
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
Arete-Zoe, LLC
 
Medical devices introduction
Medical devices introductionMedical devices introduction
Medical devices introduction
FarzadAli4
 
Medical Device Definition
Medical Device DefinitionMedical Device Definition
Medical Device Definition
Nealda Yusof
 
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Akshay Anand
 
Medical Device: A life changing innovation
Medical Device: A life changing innovationMedical Device: A life changing innovation
Medical Device: A life changing innovation
Turacoz Healthcare Solutions
 
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
Presentation: Medical Devices: how to stay included workshop - Adverse event ...Presentation: Medical Devices: how to stay included workshop - Adverse event ...
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
TGA Australia
 
Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...
Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...
Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...
TGA Australia
 
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
European Center for Disease Prevention and Control (ECDC)
 
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Australia
 
Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices
Arete-Zoe, LLC
 
TGA presentation: Lifecycle of a Medical Device / IVD
TGA presentation: Lifecycle of a Medical Device / IVDTGA presentation: Lifecycle of a Medical Device / IVD
TGA presentation: Lifecycle of a Medical Device / IVD
TGA Australia
 
Materiovigilance programme of india by akhilesh sachan
Materiovigilance programme of india by akhilesh sachanMateriovigilance programme of india by akhilesh sachan
Materiovigilance programme of india by akhilesh sachan
Akhilesh Sachan
 
mHealth Summit EU 2015
mHealth Summit EU 2015mHealth Summit EU 2015
mHealth Summit EU 2015
3GDR
 
Regulation for medical devices
Regulation for medical devicesRegulation for medical devices
Regulation for medical devices
BhagyalaxmiRanawat
 
TGA presentation: medical devices audit assessments
TGA presentation: medical devices audit assessmentsTGA presentation: medical devices audit assessments
TGA presentation: medical devices audit assessments
TGA Australia
 
Presentation: Medical Devices: how to stay included workshop - Post-market ro...
Presentation: Medical Devices: how to stay included workshop - Post-market ro...Presentation: Medical Devices: how to stay included workshop - Post-market ro...
Presentation: Medical Devices: how to stay included workshop - Post-market ro...
TGA Australia
 
TGA changes for Medical Devices in Australia
TGA changes for Medical Devices in AustraliaTGA changes for Medical Devices in Australia
TGA changes for Medical Devices in Australia
Joe Hage
 

What's hot (20)

MHRA - 18th March 2014
MHRA - 18th March 2014MHRA - 18th March 2014
MHRA - 18th March 2014
 
The regulation of IVD medical devices
The regulation of IVD medical devicesThe regulation of IVD medical devices
The regulation of IVD medical devices
 
New EU Legislation on Medical Devices By G. Bos - BSI (Qserve Conference 2013)
New EU Legislation on Medical Devices By G. Bos - BSI (Qserve Conference 2013)New EU Legislation on Medical Devices By G. Bos - BSI (Qserve Conference 2013)
New EU Legislation on Medical Devices By G. Bos - BSI (Qserve Conference 2013)
 
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
Medical Devices Regulation (MDR)  2017/745 - Clinical investigationsMedical Devices Regulation (MDR)  2017/745 - Clinical investigations
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
 
Medical devices introduction
Medical devices introductionMedical devices introduction
Medical devices introduction
 
Medical Device Definition
Medical Device DefinitionMedical Device Definition
Medical Device Definition
 
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
 
Medical Device: A life changing innovation
Medical Device: A life changing innovationMedical Device: A life changing innovation
Medical Device: A life changing innovation
 
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
Presentation: Medical Devices: how to stay included workshop - Adverse event ...Presentation: Medical Devices: how to stay included workshop - Adverse event ...
Presentation: Medical Devices: how to stay included workshop - Adverse event ...
 
Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...
Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...
Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...
 
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
The In vitro diagnostic medical devices regulation (EU) 2017/746: what will c...
 
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
 
Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices
 
TGA presentation: Lifecycle of a Medical Device / IVD
TGA presentation: Lifecycle of a Medical Device / IVDTGA presentation: Lifecycle of a Medical Device / IVD
TGA presentation: Lifecycle of a Medical Device / IVD
 
Materiovigilance programme of india by akhilesh sachan
Materiovigilance programme of india by akhilesh sachanMateriovigilance programme of india by akhilesh sachan
Materiovigilance programme of india by akhilesh sachan
 
mHealth Summit EU 2015
mHealth Summit EU 2015mHealth Summit EU 2015
mHealth Summit EU 2015
 
Regulation for medical devices
Regulation for medical devicesRegulation for medical devices
Regulation for medical devices
 
TGA presentation: medical devices audit assessments
TGA presentation: medical devices audit assessmentsTGA presentation: medical devices audit assessments
TGA presentation: medical devices audit assessments
 
Presentation: Medical Devices: how to stay included workshop - Post-market ro...
Presentation: Medical Devices: how to stay included workshop - Post-market ro...Presentation: Medical Devices: how to stay included workshop - Post-market ro...
Presentation: Medical Devices: how to stay included workshop - Post-market ro...
 
TGA changes for Medical Devices in Australia
TGA changes for Medical Devices in AustraliaTGA changes for Medical Devices in Australia
TGA changes for Medical Devices in Australia
 

Similar to Presentation: Custom-made medical devices: Information for the dental industry

COVID-19 and the FDA: What Every Manufacturing Company Needs to Know
COVID-19 and the FDA: What Every Manufacturing Company Needs to KnowCOVID-19 and the FDA: What Every Manufacturing Company Needs to Know
COVID-19 and the FDA: What Every Manufacturing Company Needs to Know
EMMAIntl
 
Presentation: Regulation of personalised, including 3D printed, medical devices
Presentation: Regulation of personalised, including 3D printed, medical devicesPresentation: Regulation of personalised, including 3D printed, medical devices
Presentation: Regulation of personalised, including 3D printed, medical devices
TGA Australia
 
EU MDR Preparation: Seize the Market Opportunity and Avoid the Bottleneck
EU MDR Preparation: Seize the Market Opportunity and Avoid the BottleneckEU MDR Preparation: Seize the Market Opportunity and Avoid the Bottleneck
EU MDR Preparation: Seize the Market Opportunity and Avoid the Bottleneck
April Bright
 
Medical device regulations
Medical device regulationsMedical device regulations
Medical device regulations
garimasaini33
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
TGA Australia
 
Presentation: Conformity assessment evidence
Presentation: Conformity assessment evidencePresentation: Conformity assessment evidence
Presentation: Conformity assessment evidence
TGA Australia
 
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Investnet
 
PECB Webinar: Proposed changes for medical device quality management systems ...
PECB Webinar: Proposed changes for medical device quality management systems ...PECB Webinar: Proposed changes for medical device quality management systems ...
PECB Webinar: Proposed changes for medical device quality management systems ...
PECB
 
Eu hot topics alliance presentation 2
Eu hot topics alliance presentation 2Eu hot topics alliance presentation 2
Eu hot topics alliance presentation 2
Erik Vollebregt
 
Eu hot topics alliance presentation
Eu hot topics alliance presentationEu hot topics alliance presentation
Eu hot topics alliance presentation
Erik Vollebregt
 
Eu hot topics alliance presentation 3
Eu hot topics alliance presentation 3Eu hot topics alliance presentation 3
Eu hot topics alliance presentation 3
Erik Vollebregt
 
Sponsor Information and Training day Session A4 - Medical Devices: Recall and...
Sponsor Information and Training day Session A4 - Medical Devices: Recall and...Sponsor Information and Training day Session A4 - Medical Devices: Recall and...
Sponsor Information and Training day Session A4 - Medical Devices: Recall and...
TGA Australia
 
Chapter 5 regulations and standards
Chapter 5 regulations and standardsChapter 5 regulations and standards
Chapter 5 regulations and standards
lahcmultimedia
 
Strategies for Device Approval in China, India, South Korea and Australia
Strategies for Device Approval in China, India, South Korea and AustraliaStrategies for Device Approval in China, India, South Korea and Australia
Strategies for Device Approval in China, India, South Korea and Australia
April Bright
 
Changing PMA or HDE Devices during COVID-19
Changing PMA or HDE Devices during COVID-19Changing PMA or HDE Devices during COVID-19
Changing PMA or HDE Devices during COVID-19
EMMAIntl
 
160428_WP_Medical_UDI_EN.PDF
160428_WP_Medical_UDI_EN.PDF160428_WP_Medical_UDI_EN.PDF
160428_WP_Medical_UDI_EN.PDF
Kuldeep Tyagi, PMP®
 
Overview of FDA Regulation of Devices & Diagnostics
Overview of FDA Regulation of Devices & DiagnosticsOverview of FDA Regulation of Devices & Diagnostics
Overview of FDA Regulation of Devices & Diagnostics
Michael Swit
 
Free webinar on Unique Device Identification
Free webinar on Unique Device IdentificationFree webinar on Unique Device Identification
Free webinar on Unique Device Identification
nykathlen
 
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
ulmedical
 
regulatory aspects of medical devices in USA
regulatory aspects of medical devices in USAregulatory aspects of medical devices in USA
regulatory aspects of medical devices in USA
navyasribandaru
 

Similar to Presentation: Custom-made medical devices: Information for the dental industry (20)

COVID-19 and the FDA: What Every Manufacturing Company Needs to Know
COVID-19 and the FDA: What Every Manufacturing Company Needs to KnowCOVID-19 and the FDA: What Every Manufacturing Company Needs to Know
COVID-19 and the FDA: What Every Manufacturing Company Needs to Know
 
Presentation: Regulation of personalised, including 3D printed, medical devices
Presentation: Regulation of personalised, including 3D printed, medical devicesPresentation: Regulation of personalised, including 3D printed, medical devices
Presentation: Regulation of personalised, including 3D printed, medical devices
 
EU MDR Preparation: Seize the Market Opportunity and Avoid the Bottleneck
EU MDR Preparation: Seize the Market Opportunity and Avoid the BottleneckEU MDR Preparation: Seize the Market Opportunity and Avoid the Bottleneck
EU MDR Preparation: Seize the Market Opportunity and Avoid the Bottleneck
 
Medical device regulations
Medical device regulationsMedical device regulations
Medical device regulations
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
 
Presentation: Conformity assessment evidence
Presentation: Conformity assessment evidencePresentation: Conformity assessment evidence
Presentation: Conformity assessment evidence
 
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
 
PECB Webinar: Proposed changes for medical device quality management systems ...
PECB Webinar: Proposed changes for medical device quality management systems ...PECB Webinar: Proposed changes for medical device quality management systems ...
PECB Webinar: Proposed changes for medical device quality management systems ...
 
Eu hot topics alliance presentation 2
Eu hot topics alliance presentation 2Eu hot topics alliance presentation 2
Eu hot topics alliance presentation 2
 
Eu hot topics alliance presentation
Eu hot topics alliance presentationEu hot topics alliance presentation
Eu hot topics alliance presentation
 
Eu hot topics alliance presentation 3
Eu hot topics alliance presentation 3Eu hot topics alliance presentation 3
Eu hot topics alliance presentation 3
 
Sponsor Information and Training day Session A4 - Medical Devices: Recall and...
Sponsor Information and Training day Session A4 - Medical Devices: Recall and...Sponsor Information and Training day Session A4 - Medical Devices: Recall and...
Sponsor Information and Training day Session A4 - Medical Devices: Recall and...
 
Chapter 5 regulations and standards
Chapter 5 regulations and standardsChapter 5 regulations and standards
Chapter 5 regulations and standards
 
Strategies for Device Approval in China, India, South Korea and Australia
Strategies for Device Approval in China, India, South Korea and AustraliaStrategies for Device Approval in China, India, South Korea and Australia
Strategies for Device Approval in China, India, South Korea and Australia
 
Changing PMA or HDE Devices during COVID-19
Changing PMA or HDE Devices during COVID-19Changing PMA or HDE Devices during COVID-19
Changing PMA or HDE Devices during COVID-19
 
160428_WP_Medical_UDI_EN.PDF
160428_WP_Medical_UDI_EN.PDF160428_WP_Medical_UDI_EN.PDF
160428_WP_Medical_UDI_EN.PDF
 
Overview of FDA Regulation of Devices & Diagnostics
Overview of FDA Regulation of Devices & DiagnosticsOverview of FDA Regulation of Devices & Diagnostics
Overview of FDA Regulation of Devices & Diagnostics
 
Free webinar on Unique Device Identification
Free webinar on Unique Device IdentificationFree webinar on Unique Device Identification
Free webinar on Unique Device Identification
 
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
 
regulatory aspects of medical devices in USA
regulatory aspects of medical devices in USAregulatory aspects of medical devices in USA
regulatory aspects of medical devices in USA
 

More from TGA Australia

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
TGA Australia
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
TGA Australia
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
TGA Australia
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
TGA Australia
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
TGA Australia
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
TGA Australia
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
TGA Australia
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changes
TGA Australia
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
TGA Australia
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
TGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
TGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
TGA Australia
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
TGA Australia
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
TGA Australia
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
TGA Australia
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA Australia
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
TGA Australia
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
TGA Australia
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Australia
 
Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...
TGA Australia
 

More from TGA Australia (20)

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changes
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
 
Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...
 

Recently uploaded

Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
chandankumarsmartiso
 

Recently uploaded (20)

Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
 

Presentation: Custom-made medical devices: Information for the dental industry

  • 1. Custom-made medical devices Information for the dental industry Valerie Mercer Director Medical Devices Information and Education Medical Devices Branch Therapeutic Goods Administration ADIA industry briefing 12-13 July 2016
  • 2. Discussion topics • Legislative framework • What is custom-made? • Notifying TGA • Regulatory obligations - pre-market - post-market ADIA industry briefing 12-13 July 2016 1
  • 3. Regulatory framework Commonwealth legislation • Therapeutic Goods Act 1989 especially Chapter 4 Medical Devices • Therapeutic Goods (Medical Devices) Regulations 2002 • https://www.tga.gov.au/legislation-legislative-instruments ADIA industry briefing 12-13 July 2016 2
  • 6. Definitions Medical device • s41BD of the Act defines a medical device as … ADIA industry briefing 12-13 July 2016 5
  • 7. Definitions Custom-made medical device • the Regulations define a custom-made medical device as …. • examples relevant to the dental industry may include: - crowns - bridges - dentures - specialised instruments ADIA industry briefing 12-13 July 2016 6
  • 8. ‘Customised’ does not equal a custom-made medical device • an existing medical device that is adapted, altered, fashioned, modified or ‘customised’ to fit a patient is NOT a custom-made medical device • for example, a preformed permanent dental crown that may require minimal fashioning in situ during restorative work is not a custom-made medical device • devices already included on the ARTG that are combined and adapted for an individual (provided the devices are used as intended by the manufacturer/IFUs) are not custom-made medical devices (orthodontic braces) ADIA industry briefing 12-13 July 2016 7
  • 9. Definitions Manufacturer • s41BG of the Act defines a manufacturer as … ADIA industry briefing 12-13 July 2016 8
  • 10. Definitions Sponsor • s3 of the Act defines a sponsor as … • sometimes the sponsor and the manufacturer are the same entity e.g. a dental laboratory that supplies their products directly to dental professionals • dentists and allied oral healthcare providers can import custom-made devices from overseas, but in doing so they become the sponsor and acquire obligations 9
  • 11. Definitions Kinds of devices • s41BE of the Act defines kinds of medical devices as … • TGA needs to be notified of each kind of device • TGA does not need to be notified about each individual device being made for individual patients ADIA industry briefing 12-13 July 2016 10
  • 12. Kinds of medical devices - examples Example 1 Dentist (sponsor) imports polymer dental bridges manufactured by Manufacturer A in China: - same sponsor - same manufacturer - same GMDN code - same classification Therefore same kind of medical device and only one notification to TGA required. Do not need to notify TGA for each patient receiving a custom-made medical device of this kind. Example 2 Dentist (sponsor) imports polymer dental bridges manufactured by Manufacturer A in China and Manufacturer B in Germany: - same sponsor - different manufacturers - same GMDN code - same classification Therefore not the same kind of medical device and separate notifications required for each kind. Again, do not need to notify TGA for each patient, only the kind of device. ADIA industry briefing 12-13 July 2016 11
  • 13. Regulatory obligations Who has obligations? • both the manufacturer and the sponsor have obligations • requirements to: - meet the essential principles (EPs) - this demonstrates the quality, safety and performance of the device - apply a conformity assessment procedure - this generates evidence that the device complies with the EPs - notify the TGA - comply with advertising requirements - report adverse events But aren’t custom-made devices ‘exempt’? • exempt from ARTG inclusion only • all other obligations still apply ADIA industry briefing 12-13 July 2016 12
  • 14. Requirement to notify TGA • since 2002, Australian manufacturers and sponsors importing custom-made medical devices into Australia have been required to notify TGA about certain details, e.g. name and business address, description of the ‘kind of device’ • in February 2016 the regulations were amended to introduce a two month timeframe for notification to the TGA • details in Regulation 10.3 ADIA industry briefing 12-13 July 2016 13
  • 15. How to notify … • simple web-based notification form • quick and easy to complete and submit • some fields mandatory • within 2 months of the device being manufactured in Australia or first imported into Australia www.tga.gov.au/custom-made-medical-devices ADIA industry briefing 12-13 July 2016 14
  • 16. 15
  • 17. 16
  • 18. 17
  • 19.
  • 20. 19
  • 21. 20
  • 22. Other regulatory obligations Essential Principles • Regulations Schedule 1, Part 1 (general principles) and Part 2 (principles about design and construction) • manufacturer must meet the applicable essential principles • sponsor must ensure device meets applicable essential principles • some EPs may not apply to the device (e.g. if the custom-made medical device is not supplied in a sterile state, the essential principles regarding sterility are not relevant and will not need to be met) • some essential principles apply only to custom-made medical devices: - information that must be provided with a medical device - an indication that the device has been custom- made for a particular individual or health professional and is intended for use only by that individual or health professional must be provided with a custom-made medical device - instructions for use (if required) must include an indication that the device has been custom-made for a particular individual or health professional and is intended for use only by that individual or health professional • there is an ‘essential principles checklist’ on TGA’s website which may be helpful (not mandatory) ADIA industry briefing 12-13 July 2016 21
  • 23. Other regulatory obligations Conformity assessment procedures The manufacturer is required to: • prepare and sign a written statement containing specific information (detailed in the Regs sched 3 item 7.2) • prepare documentation relating to the design, production and intended performance of the device (and keep the documentation up-to-date) • take all measures necessary to ensure that the manufacturing process results in the device complying with the documentation mentioned above • notify the TGA as soon as practicable of certain events that might lead (or might have led) to the death or serious deterioration of the state of health of the patient or user, or caused the manufacturer to recover a device that has been distributed. Examples of these events include malfunction, deterioration and inadequacy in the design, production, labelling or instructions for use. The sponsor is required to ensure that the manufacturer has applied the conformity assessment procedures. ADIA industry briefing 12-13 July 2016 22
  • 24. About the ‘statement’ Details to be included: • name and business address of manufacturer • information to identify the device • statement that manufacturer intends device to be used only for a particular individual or health professional • name of the individual or health professional • name and business address of health professional that provided device specifications • particular design characteristics or construction provided by health professional • a statement that the device complies with the applicable essential principles, or a statement explaining which essential principles it does not comply with and reasons for the non-compliance Statement to be signed and dated by an authorised person (from the manufacturer) and kept up-to-date ADIA industry briefing 12-13 July 2016 23
  • 25. Therapeutic Goods Advertising Code 2015 General Principles Section 4 sets out the key requirements including that therapeutic good advertisements “must not”: • Mislead or be likely to mislead • Arouse unrealistic expectations of product effectiveness • Lead consumers to self-diagnosing, inappropriately treating or believing they have a serious disease • Abuse consumers’ trust or exploit their lack of knowledge • Encourage inappropriate or excessive use • Claim that a good is guaranteed, certain, sure cure or that the goods are completely safe or harmless • Be directed to minors (subject to exceptions) https://www.legislation.gov.au/Details/F2015L01787 ADIA industry briefing 12-13 July 2016 24
  • 26. Adverse events What to report 25ADIA industry briefing 12-13 July 2016
  • 27. Summary • Both manufacturers and sponsors/suppliers of custom-made medical devices have obligations • ‘Custom-made’ has a specific meaning and is defined in the regulatory framework (not customised/adapted) • Custom-made devices have specific requirements for information to be supplied with the device • Custom-made devices are exempt from ARTG inclusion, but other obligations still apply • Timeframe for notifying TGA of custom-made devices is 2 months - from initial manufacture (if manufactured in Australia) - from initial importation/supply in Australia (if manufactured overseas) • Notifying TGA is only one obligation – others include: - device must meet essential principles - device must have had conformity assessment procedure applied - adverse events must be reported to TGA ADIA industry briefing 12-13 July 2016 26

Editor's Notes

  1. If a dental technician or prosthetist: uses devices (raw materials) included on the ARTG in accordance with their intended purpose, then the technician/prosthetist is adapting devices for an individual and is neither a manufacturer or sponsor uses devices (raw materials) included on the ARTG but not in accordance with their intended purpose, then they are manufacturing custom-made devices uses raw materials not included on the ARTG, they are manufacturing custom-made medical devices   Examples: an orthodontist uses a number of devices included on the ARTG (e.g. orthodontic metal bands, orthodontic springs, orthodontic archwire, etc) for the purpose intended by the manufacturer (i.e. to make braces for a specific individual) the orthodontist is adapting these devices for a specific individual (i.e. not a manufacturer) a dental technician using a polymer-based dental material to make a denture base as detailed in the product’s IFU is adapting the material for a specific individual (not a manufacturer) a dental prosthetist that uses an ARTG included dental crown resin (a composite material intended to be used for veneering metallic dental crowns) to make a hard denture base (i.e. not in accordance with the IFUs) is a making a custom-made device and meets the definition of a manufacturer. Note: GMDN 61718 – Preformed dental crown, permanent A prefabricated prosthetic device designed to function as a permanent artificial covering to partially or fully replace the damaged crown of a tooth. It is made of ceramic and polymer materials and may require minimal fashioning in situ during restorative work. It is available as a single prosthesis or multiple prostheses of various shapes and sizes, and may include one or more try-in prosthesis replicas and other devices intended to assist the restoration procedure (e.g. disposable prosthesis gauge).
  2. Examples: A legal entitiy in China that designs, produces, packages, labels with their own name and exports (including to Australia) pre-formed permanent crowns is a manufacturer. An individual based in Canberra imports large numbers of dental implant template retention pins that are manufactured in Germany, but packages the dental pins into smaller units, labels the packaging with their own names and supplies/sells the dental pins to other dental laboratories in Australia (or overseas) is a manufacturer and sponsor. A dental laboratory based in Melbourne that: imports (from overseas) non ARTG included polymer material, dental implant template retention pins and other items necessary for their dental technicians to produce dental crowns (in accordance with specifications provided by a dentist) – is a manufacturer of custom-made devices and also packages, labels and sells the crowns to other dental laboratories –is a manufacturer and sponsor.
  3. In order to be legally supplied in Australia, most medical devices must be included in the ARTG. This is where custom-made medical devices differ. Custom-made medical devices do not need to be included in the ARTG but they must still meet the other requirements, i.e. quality, safety and performance. Several means by which ‘unauthorised medical devices’ (i.e. those not included in the ARTG) can be legally supplied in Australia: custom-made medical devices clinical trials scheme authorised prescriber scheme special access scheme Custom-made medical devices do not need to be included in the ARTG but must comply with all other obligations.
  4. In this instance, like many others, the functions of the Secretary of the Department of Health have been delegated to officers within the TGA. Therefore ‘give the following information to the Secretary’ means give the info to the TGA. The Regulations were amended in early 2016 following requests from the dental industry bodies: - in recognition that the majority of people in the industry want to comply with the regulatory obligations - to clarify the timeframe of the obligation to notify - in addition, TGA provided a simple means of notification, i.e. the web-based notification/reporting form
  5. If the custom-made device is manufactured in Australia, the Australian manufacturer must notify the TGA If the custom-made device is imported into Australia by a dentist, dental laboratory, etc but is manufactured overseas, the sponsor must notify the TGA (i.e. whoever imports and supplies the device in Australia – and this includes supplying/implanting/affixing it to a patient)
  6. Select manufacturer or sponsor. In some circumstances this is the same entity. TGA is planning to amend the form so that this option is available. The first example demonstrates how a manufacturer will complete the form, i.e. an Australian manufacturer (manufacturers located overseas are not required to notify TGA – in this instance the obligation to notify is transferred to the Australian sponsor who imports and supplies).
  7. The mandatory fields are simple details: Manufacturer’s name and business address Sponsor’s name and address Brief description of the device Classification of the device Note that GMDN code is not a mandatory field. Codes are available through GMDN Agency membership (cost involved) or through TGA Business Services (must have client id and mock up an ARTG application). Other non-mandatory details include contact info (email and phone) which TGA may need to use in case of post-market activities or recalls .
  8. This is the page you will see once you have successfully completed a notification. You can immediately download a copy of the completed form or have a copy emailed to any address you enter here (may or may not be the same email address you gave when you completed the form – either way you will need to enter the email address here).
  9. If you nominate to have an emailed version sent to you, this is the email you will receive. Note that the completed form is an attachment ….
  10. This is the view you will see once you open the attachment. Again you can save a copy of this if you choose.
  11. The form has some additional fields for completion if you are a sponsor. You will need to include the manufacturer’s details (often an overseas manufacturer, but may be an Australian manufacturer) as well as your own details as the sponsor. Just like we saw when an Australian manufacturer completes the notification, the sponsor receives the same option to download a copy of the completed form or receive it as an attachment to an email. Question: does an Australian manufacturer of custom-made medical devices need to notify if they only export? Answer: Not explicitly required but the intention of the legislation appears to be for application to custom-made devices that will be supplied in Australia. However, this could be interpreted to apply to export-only also.
  12. Notifying TGA about the manufacture or importation of custom-made medical devices is one of several obligations which the Australian manufacturer and sponsor are required to meet/satisfy. Essential principles – demonstrate the quality, safety and performance of the device – this is especially important if the device is manufactured overseas (if manufactured in Australia the manufacturer will also be notifying TGA and meeting the essential principles) Conformity assessment procedure – a procedure that generates the evidence that the device complies with the essential principles Prepare and keep up to date a statement about the device Comply with advertising requirements Report adverse events Chapter 4 of the Act details penalties for importing, supplying or exporting a medical device that does not comply with the essential principles: - s41MA lists criminal offences – 12 months prison or fine or both - s41MAA lists civil offences – fines for individuals and bodies corporate Importing and supplying and exporting A person commits an offence if the person imports/supplies/exports a device and: - use of the device has resulted in harm or injury to any person - use of the device will result in harm or injury to any person - use of the device would be likely to result in harm or injury to any person - the harm or injury is because the devices does not comply with the essential principles (other than labelling) and - the secretary has not consulted to the importation/supply/export and the device is not of a kind covered by an exemption (i.e. national interest such as for stockpiling for emergency preparedness or to deal with an actual threat to public health caused by an emergency) Penalty: imprisonment for 12 months or a fine (or both)
  13. If the Australian sponsor is supplying a product that was manufactured overseas, then the sponsor/supplier is taking responsibility for the device and making assurances that it is manufactured in accordance with the essential principles (i.e. it is of appropriate quality, is safe and will perform as intended).
  14. The manufacturer must prepare the statement and keep it up-to-date, but there is no need to provide it to TGA unless requested.
  15. Object of the Advertising Code To ensure that the marketing and advertising of therapeutic goods to consumers is conducted in a manner that promotes the quality use of therapeutic goods, is socially responsible and does not mislead or deceive the consumer Assessed in terms of probable impact upon a reasonable person to whom the advertisement is directed. Advertising Tips Hold the appropriate level of evidence Claims must be consistent with intended purpose No references to prohibited or unapproved restricted representations, “TGA approved” or to the product being safe Endorsements and testimonials must comply fully with the Code Include mandatory warning statements Advertising Complaints Complaints about medical device advertisements directed to the public that do not comply with the advertising requirements can be made to the: Complaints Resolution Panel – TV, radio, newspapers, magazines, cinemas, posters Medical Technology Association of Australia – in-store material, brochures Therapeutic Goods Administration Complaints considered by the Complaints Resolution Panel may result in the advertiser being requested to take certain actions. The Panel may make a recommendation to the Secretary of the Department of Health (TGA) where the Advertiser fails to respond, or fails to indicate an intention to comply fully with Panel’s requests.
  16. Again, the Secretary has delegated this function to officers within the TGA. We commonly refer to these occurrences as post-market issues or adverse events. Note that the manufacturer and sponsor have obligations to report adverse events to the TGA and the Regulations provide penalties if this is not done within prescribed timeframes. The Regulations also state the manufacturer must notify the TGA as soon as practicable after becoming aware of: (a) an information relating to: (i) any malfunction or deterioration in the characteristics or performance of the device (ii) any inadequacy in the design, production, labelling or instructions for use of the device (iii) any use in accordance with, or contrary to, the used intended by the manufacturer of the device that might lead, or might have led, to the death of a patient or a user of the device, or to a serious deterioration in his or her state of health (b) information relating to any technical or medical reason for a malfunction or deterioration of the kind mentioned above that has lead the manufacturer to take steps to recover a device that has been distributed